JIP
GH icon

Jaffetilchin Investment Partners’s Guardant Health GH Stock Holding History

Jaffetilchin Investment Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,333
Closed -$356K – 386
2021
Q1 		$356K Buy
+2,333
New +$353K 0.04% 242

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jaffetilchin Investment Partners's GH Position: Q2 2021 in Review

Jaffetilchin Investment Partners sold out of Guardant Health (GH) in Q2 2021, closing a stake of 2,333 shares — an estimated $356K sold.

Jaffetilchin Investment Partners first reported a position in GH in Q1 2021 and held it in 1 quarter. The position peaked at $356K in Q1 2021. 417 funds tracked by Wall St. Rank hold GH as of Q2 2021.

  • Jaffetilchin Investment Partners reported no remaining Guardant Health position as of Q2 2021 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 2,333 Guardant Health shares in Q2 2021, an estimated $356K.
  • Jaffetilchin Investment Partners first reported a position in Guardant Health in Q1 2021 and held it in 1 quarter.
  • Jaffetilchin Investment Partners's Guardant Health position peaked at $356K in Q1 2021.
  • 417 funds tracked by Wall St. Rank held Guardant Health as of Q2 2021.

Based on Jaffetilchin Investment Partners's 13F filing for Q2 2021, filed 9 Aug 2021.